Twin to Twin Transfusion Syndrome: Diagnosis, Outlook, and Modern Treatment Approaches

Twin to twin transfusion syndrome is a complication that can occur in identical twins who share one placenta, causing unbalanced blood flow between the babies. Early ultrasound monitoring, accurate staging, and timely fetal treatment can significantly improve outcomes in many pregnancies.

Overview: what twin to twin transfusion syndrome means

Twin to twin transfusion syndrome is a condition that can develop when identical twins share a single placenta, also called a monochorionic pregnancy. In this situation, blood vessel connections within the placenta may allow blood to flow unevenly from one twin to the other. One baby, often called the donor twin, can give away too much blood, while the recipient twin may receive too much.

This imbalance can place strain on both babies in different ways. The donor twin may have reduced blood volume, slower growth, and too little amniotic fluid. The recipient twin may develop excess blood volume, too much amniotic fluid, and extra pressure on the heart and circulation. The condition can range from mild to severe, which is why specialist follow-up is so important.

Twin to twin transfusion syndrome only occurs in twins that share a placenta. It does not happen in twins with separate placentas. Because the condition can develop and change over a short period of time, pregnancies at risk are usually monitored more closely than other twin pregnancies.

How TTTS develops in a shared placenta

The placenta of a monochorionic twin pregnancy often contains natural blood vessel connections between the twins. Many shared-placenta twin pregnancies have these connections and remain stable. TTTS develops when the flow through these vessel connections becomes unbalanced enough to cause one twin to lose more blood than it receives, while the other receives more than it returns.

This process affects more than blood volume alone. The donor twin often makes less urine because less blood reaches the kidneys, leading to a low amount of amniotic fluid. The recipient twin often makes more urine because of increased blood flow, resulting in high amniotic fluid. These fluid differences are often the first signs seen on ultrasound.

TTTS is different from other monochorionic twin complications, including selective fetal growth restriction or twin anemia-polycythemia sequence. In some pregnancies, related conditions may overlap, so a specialist evaluation is needed to define the exact problem and choose the most appropriate care plan. Careful fetal imaging, including advanced ultrasound imaging, helps clarify what is happening inside the uterus.

Symptoms and ultrasound signs doctors look for

Many pregnant patients do not feel clear symptoms in the early stages of twin to twin transfusion syndrome. That is one reason routine screening is so important in monochorionic twin pregnancies. TTTS is often first suspected during a scheduled ultrasound rather than because of symptoms felt at home.

When symptoms do occur, they may be related to rapidly increasing amniotic fluid around the recipient twin. A pregnant person may notice a sudden increase in abdominal size, abdominal tightness, discomfort, contractions, pelvic pressure, shortness of breath, or a feeling that the uterus has become unusually tense. These symptoms do not always mean TTTS is present, but they should be discussed promptly with the care team.

On ultrasound, specialists assess amniotic fluid around each twin, bladder filling, fetal growth, movement, and blood flow patterns. Typical findings may include:

• Too little amniotic fluid around the donor twin
• Too much amniotic fluid around the recipient twin
• A bladder that is difficult to see in the donor twin
• Signs of strain on the recipient twin’s heart
• Differences in blood flow on Doppler ultrasound

Doctors may also use a staging system, commonly the Quintero stages, to describe severity. Staging helps teams communicate clearly and plan monitoring or treatment, but the whole clinical picture matters, not just the stage number.

Who is at risk and how the condition is diagnosed

The main risk factor for twin to twin transfusion syndrome is a monochorionic twin pregnancy, meaning twins share one placenta. This most often occurs with identical twins. The condition generally becomes a concern during the second trimester, though monitoring begins earlier once placental sharing has been confirmed.

Diagnosis starts with identifying chorionicity, or how many placentas are present. Early pregnancy ultrasound is especially useful for this. Once a monochorionic pregnancy is confirmed, regular follow-up scans are recommended to look for fluid imbalance, growth differences, and circulatory changes. In many cases, ultrasounds are scheduled every two weeks starting in the second trimester, although exact timing depends on the individual pregnancy.

Diagnostic evaluation may include detailed fetal anatomy assessment, Doppler studies of blood flow, cervical length measurement, and echocardiographic assessment of the babies’ hearts when needed. The goal is not only to confirm TTTS but also to rule out similar conditions and identify any urgent signs that might affect timing of treatment. If another twin complication is present, such as high-risk pregnancy concerns more broadly, the care plan may need to be adjusted.

Treatment options and modern fetal therapy

Treatment depends on gestational age, stage of disease, ultrasound findings, and the overall condition of both twins. Mild cases may be managed with close surveillance, especially if the findings are borderline or stable. Monitoring may include frequent ultrasound examinations to track amniotic fluid, fetal growth, blood flow, and heart function.

In more significant TTTS, treatment aims to reduce the harmful effects of fluid and circulation imbalance. Amnioreduction, which removes some excess amniotic fluid, may be considered in selected situations. It can relieve pressure in the uterus, but it does not correct the underlying placental vessel imbalance. Because of this, it is not always the preferred definitive treatment.

For many cases of moderate to severe TTTS diagnosed during the mid-trimester, fetoscopic laser photocoagulation is considered the standard fetal therapy. In this procedure, a specialist uses a small fetoscope to identify and seal the placental blood vessel connections responsible for the imbalance. This approach addresses the cause of TTTS rather than only its effects. A patient may be referred to a center with expertise in fetal surgery and high-risk pregnancy care for this procedure.

Additional care may include maternal monitoring, medications when appropriate, planning for preterm birth risk, and neonatal support after delivery. Some patients may also need hospital observation if contractions, severe fluid changes, or cervical shortening develop. In complex situations, multidisciplinary teams may combine maternal-fetal medicine, neonatology, radiology, and pediatric subspecialty input to guide treatment and timing of delivery.

Outlook, pregnancy follow-up, and life after treatment

The outlook for twin to twin transfusion syndrome varies widely. It depends on how early the condition is detected, how severe it becomes, how the twins respond, and whether fetal treatment is needed. Earlier diagnosis and referral to experienced specialists generally improve the chance of stabilizing the pregnancy and supporting the best possible outcome for one or both babies.

Even after successful treatment, ongoing monitoring remains essential. Doctors continue to watch fetal growth, amniotic fluid, blood flow, and signs of preterm labor. Follow-up also looks for related concerns that can occasionally occur after laser treatment, including anemia or growth differences. Delivery planning is individualized based on fetal well-being, gestational age, and maternal health.

After birth, the babies may need neonatal assessment and, in some cases, care in a newborn intensive care unit if they are premature or have effects related to TTTS. Long-term outcomes depend on the course of the pregnancy and any complications that occurred before birth or during the newborn period. Families often benefit from clear counseling, regular updates, and coordinated communication across the obstetric and neonatal teams.

In specialized centers, evaluation may involve maternal-fetal medicine experts together with neonatal and pediatric teams, and selected patients may also need perinatology follow-up. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat complex twin pregnancy conditions for international patients when advanced evaluation is needed.

Prevention, self-care, and when to seek medical care

There is no proven way to prevent twin to twin transfusion syndrome from developing in a monochorionic twin pregnancy. The most effective step is early confirmation that twins share a placenta and then consistent prenatal surveillance. Keeping all appointments, reporting new symptoms promptly, and following the advice of a high-risk pregnancy team can help problems be recognized early.

Self-care during pregnancy still matters, although it cannot stop TTTS on its own. General measures include staying well hydrated unless advised otherwise, tracking symptoms, resting when needed, and seeking support for the emotional stress that a high-risk twin pregnancy can bring. It can also help to ask the care team what warning signs should lead to urgent contact between scheduled visits.

Medical review should be sought promptly if there is sudden abdominal enlargement, marked abdominal tightness, contractions, pelvic pressure, decreased fetal movement later in pregnancy, vaginal bleeding, leaking fluid, or shortness of breath. Any patient carrying monochorionic twins who feels that symptoms are changing quickly should contact their obstetric team without delay.

Referral to a fetal medicine specialist is especially important if ultrasound suggests TTTS or another placental sharing complication such as multiple pregnancy risks that require advanced care. Early specialist input can help confirm the diagnosis, explain the options, and decide whether surveillance or intervention is most appropriate.

Frequently asked questions

Is twin to twin transfusion syndrome the same as all twin pregnancy complications?

No. Twin to twin transfusion syndrome is a specific complication of monochorionic twin pregnancies, where twins share one placenta and blood flow becomes unbalanced. Other twin pregnancy problems, such as growth restriction or preterm birth, can happen for different reasons.

Can TTTS be found before symptoms appear?

Yes. TTTS is often detected on routine ultrasound before the pregnant person notices any symptoms. This is why regular scanning is a key part of care in pregnancies where twins share a placenta.

Does TTTS always require surgery?

No. Some mild or borderline cases are managed with close monitoring rather than an immediate procedure. More advanced cases may need fetal therapy, often fetoscopic laser treatment, depending on stage and gestational age.

What is the purpose of laser treatment for TTTS?

Laser treatment aims to seal the abnormal placental vessel connections that are causing the uneven blood flow. By treating the source of the imbalance, it can improve the chances of stabilizing the pregnancy.

Can both babies survive twin to twin transfusion syndrome?

In many pregnancies, both babies can survive, especially when the condition is recognized early and managed by an experienced team. However, outcomes vary depending on severity, timing, and whether complications develop.

Will a pregnancy still need close follow-up after treatment?

Yes. Even after treatment, continued ultrasound monitoring is very important. Doctors need to check growth, fluid levels, blood flow, and signs of preterm labor or related twin complications.

References

• Society for Maternal-Fetal Medicine
• American College of Obstetricians and Gynecologists
• International Society of Ultrasound in Obstetrics and Gynecology
• National Institute for Health and Care Excellence
• Centers for Disease Control and Prevention

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.